VetEvolve names Dr. Laura Pletz its first chief veterinary officer
Bottom line
VetEvolve has appointed Dr. Laura Pletz as its first chief veterinary officer, adding a new clinical leadership role as the practice group continues to expand. The company said July 13 that Pletz joins the executive team after serving most recently as divisional vice president of medicine at BluePearl Specialty and Emergency Pet Hospital. VetEvolve said the new role is meant to strengthen clinical quality, professional development, and support for veterinarians across its network, which it described as 53 partner practices across the Mid-Atlantic and Southeast. Pletz previously worked in independent practice, became a practice owner, and later held leadership roles at Royal Canin and BluePearl. (vetevolve.com)
Why it matters: For veterinary professionals, the move signals how larger practice groups are putting more formal medical leadership in place as they scale. VetEvolve said feedback from its practices pointed to a need for added clinical leadership, mentorship, and professional development support, suggesting the CVO role is intended to help balance growth with consistency in care standards and veterinarian support. That could matter for recruiting, retention, clinician autonomy, and the day-to-day translation of company strategy into medical practice. (cl.linkedin.com)
What to watch: Watch for how quickly VetEvolve defines the scope of the new CVO role, especially around medical standards, mentorship, and integration across its partner hospitals. (vetevolve.com)
VetEvolve has named Dr. Laura Pletz as chief veterinary officer, creating the role for the first time as the company grows its network of partner practices. In announcing the appointment on July 13, VetEvolve said Pletz will join the executive team and work with practice leaders to strengthen clinical quality, advance professional development, and support veterinarians across the organization. (vetevolve.com)
The appointment comes as veterinary groups continue to build out more formal clinical leadership structures alongside operational growth. VetEvolve, founded in 2014, said it has grown to 53 practices across the Mid-Atlantic and Southeast and is backed by Varsity Healthcare Partners. The company framed the new CVO post as part of a broader investment in the people delivering care, not just in expansion itself. (vetevolve.com)
Pletz brings experience from several corners of the profession. VetEvolve said she has more than 20 years of leadership experience spanning independent practice, specialty and emergency medicine, and multi-site medical operations. According to BluePearl’s leadership profile, she earned her DVM from the University of Missouri College of Veterinary Medicine in 2000, spent 11 years in small animal medicine as one of a clinic’s practice owners, then moved into veterinary leadership roles at Royal Canin before joining BluePearl in 2023 as a group medical director and later becoming divisional vice president of medicine. (vetevolve.com)
VetEvolve and Pletz both emphasized support for clinicians and preservation of local practice identity. In the company’s announcement, Pletz said she was drawn to VetEvolve’s commitment to supporting veterinarians while preserving what makes each practice special. VetEvolve’s LinkedIn post added that practice feedback reinforced the value of more clinical leadership, mentorship, and professional development support, giving a clearer signal that the role may be shaped as much by workforce needs as by governance. (vetevolve.com)
Pletz also arrives with a visible leadership profile outside hospital operations. VetEvolve noted that she is a past president of the Women’s Veterinary Leadership Development Initiative, and a 2023 WVLDI post confirms she was serving as president at that time. VetEvolve also highlighted her recognition as a Pet Age Women of Influence honoree and one of the Top 50 Women Leaders in St. Louis. (vetevolve.com)
Why it matters: For veterinary professionals, this appointment is notable less because of the title itself and more because of what it suggests about where consolidators are putting resources. A first-time CVO role usually means a company wants tighter alignment between growth, medical quality, clinician development, and culture. If VetEvolve gives the role real authority over mentorship, standards, and medical decision support, it could help practices navigate one of the hardest balancing acts in the sector: scaling without making veterinarians feel farther from leadership or less supported in practice. That’s particularly relevant in a market still shaped by staffing pressure, burnout concerns, and competition for experienced clinicians. The company’s own messaging suggests it sees clinical leadership as a retention and practice-support tool, not just an executive title. This is an inference based on VetEvolve’s stated rationale and description of the role. (vetevolve.com)
What to watch: The next step is whether VetEvolve translates the appointment into visible programs, such as clinical pathways, mentorship initiatives, continuing education support, or medical quality infrastructure, and how quickly those efforts show up across its 53-practice network. (vetevolve.com)